Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cardinal Closes $1.2B Divestiture of its China biz to Shanghai Pharma | Contract Pharma
Breaking News

Cardinal Closes $1.2B Divestiture of its China biz to Shanghai Pharma

Sale includes Cardinal's pharmaceutical and medical products distribution business in China

Cardinal Health has closed its divestiture of its Cardinal Health China business to Shanghai Pharmaceuticals. The sale includes Cardinal Health’s pharmaceutical and medical products distribution business in China. The divestiture does not include Cardinal Health’s remaining businesses in China, including Cordis, its recently acquired patient recovery business, its medical sourcing team or other functions.

The gross proceeds of the transaction are $1.2 billion; the net proceeds are approximately $800 million after adjusting for third party indebtedness, withholding taxes, and other transaction expenses and adjustments. Cardinal Health plans to provide more detail on this divestiture in connection with its second quarter earnings call scheduled for February 8, 2018.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters